Calidi Biotherapeutics prices registered direct offering at USD 1.17 a share to raise USD 1.2 million - CLDI News | RalliesCalidi Biotherapeutics prices registered direct offering at USD 1.17 a share to raise USD 1.2 million
C
CLDI• Registered direct offering details
- Calidi Biotherapeutics set a $1.2 million registered direct offering of 1,025,640 common shares priced at $1.17 each.
- Closing is expected around Sept. 18, 2026, subject to customary conditions.
- Net proceeds are earmarked for working capital and general corporate purposes.
•
